{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:28:00Z","timestamp":1793755680240,"version":"4.6.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10815-026-03980-5","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:59:30Z","timestamp":1785455970000},"page":"2995-3000","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Restoration of spermatogenesis in a male with prolactinoma-induced hypogonadotropic hypogonadism using follitropin delta and recombinant choriogonadotropin alfa: a case report"],"prefix":"10.1007","volume":"43","author":[{"given":"Moises Abraham","family":"Adel Dom\u00ednguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter D.","family":"Cardona Maya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Mora Topete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"3980_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00322","volume":"10","author":"HM Behre","year":"2019","unstructured":"Behre HM. Clinical use of FSH in male infertility. Front Endocrinol (Lausanne). 2019;10: 322. https:\/\/doi.org\/10.3389\/fendo.2019.00322.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3980_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/andr.70003","author":"SC Esteves","year":"2025","unstructured":"Esteves SC, Viana MC, Achermann APP, Santi D. Human chorionic gonadotropin-based clinical treatments for infertile men with non-obstructive azoospermia. Andrology. 2025. https:\/\/doi.org\/10.1111\/andr.70003.","journal-title":"Andrology"},{"key":"3980_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1338345","volume":"15","author":"L Dzialach","year":"2024","unstructured":"Dzialach L, Sobolewska J, Zak Z, Respondek W, Witek P. Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment. Front Endocrinol (Lausanne). 2024;15: 1338345. https:\/\/doi.org\/10.3389\/fendo.2024.1338345.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3980_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/bs.vh.2024.11.001","volume":"129","author":"Y Rudman","year":"2025","unstructured":"Rudman Y, Shimon I. Hypogonadism in men with prolactinoma: diagnosis, treatment, and management of persistent hypogonadism. Vitam Horm. 2025;129:185\u2013202. https:\/\/doi.org\/10.1016\/bs.vh.2024.11.001.","journal-title":"Vitam Horm"},{"issue":"9","key":"3980_CR5","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1210\/clinem\/dgad174","volume":"108","author":"RS Auriemma","year":"2023","unstructured":"Auriemma RS, Pirchio R, Pivonello C, Garifalos F, Colao A, Pivonello R. Approach to the patient with prolactinoma. J Clin Endocrinol Metab. 2023;108(9):2400\u201323. https:\/\/doi.org\/10.1210\/clinem\/dgad174.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"3980_CR6","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1210\/er.2005-9998","volume":"27","author":"MP Gillam","year":"2006","unstructured":"Gillam MP, Molitch ME, Lombardi G, Colao A. Advances in the treatment of prolactinomas. Endocr Rev. 2006;27(5):485\u2013534. https:\/\/doi.org\/10.1210\/er.2005-9998.","journal-title":"Endocr Rev"},{"issue":"13","key":"3980_CR7","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1056\/NEJMcp0912025","volume":"362","author":"A Klibanski","year":"2010","unstructured":"Klibanski A. Clinical practice. Prolactinomas N Engl J Med. 2010;362(13):1219\u201326. https:\/\/doi.org\/10.1056\/NEJMcp0912025.","journal-title":"Prolactinomas N Engl J Med"},{"issue":"5","key":"3980_CR8","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s11102-024-01445-5","volume":"27","author":"SM Constantinescu","year":"2024","unstructured":"Constantinescu SM, Maiter D, Alexopoulou O. Recovery from hypogonadism in men with prolactinoma treated with dopamine agonists. Pituitary. 2024;27(5):625\u201334. https:\/\/doi.org\/10.1007\/s11102-024-01445-5.","journal-title":"Pituitary"},{"issue":"6","key":"3980_CR9","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1586\/17446651.2014.949239","volume":"9","author":"L Vroonen","year":"2014","unstructured":"Vroonen L, Daly AF, Beckers A. Challenges and controversies in the treatment of prolactinomas. Expert Rev Endocrinol Metab. 2014;9(6):593\u2013604. https:\/\/doi.org\/10.1586\/17446651.2014.949239.","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"4","key":"3980_CR10","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1210\/jc.2003-030979","volume":"89","author":"A Colao","year":"2004","unstructured":"Colao A, Vitale G, Cappabianca P, Briganti F, Ciccarelli A, De Rosa M, et al. Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis. J Clin Endocrinol Metab. 2004;89(4):1704\u201311. https:\/\/doi.org\/10.1210\/jc.2003-030979.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"3980_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24109020","volume":"24","author":"M Lispi","year":"2023","unstructured":"Lispi M, Humaidan P, Bousfield GR, D\u2019Hooghe T, Ulloa-Aguirre A. Follicle-stimulating hormone biological products: does potency predict clinical efficacy? Int J Mol Sci. 2023;24(10): 9020. https:\/\/doi.org\/10.3390\/ijms24109020.","journal-title":"Int J Mol Sci."},{"issue":"11","key":"3980_CR12","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/jcph.328","volume":"54","author":"H Olsson","year":"2014","unstructured":"Olsson H, Sandstrom R, Grundemar L. Different pharmacokinetic and pharmacodynamic properties of recombinant follicle-stimulating hormone (rFSH) derived from a human cell line compared with rFSH from a non-human cell line. J Clin Pharmacol. 2014;54(11):1299\u2013307. https:\/\/doi.org\/10.1002\/jcph.328.","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"3980_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1530\/EC-17-0067","volume":"6","author":"W Koechling","year":"2017","unstructured":"Koechling W, Plaksin D, Croston GE, Jeppesen JV, Macklon KT, Andersen CY. Comparative pharmacology of a new recombinant FSH expressed by a human cell line. Endocr Connect. 2017;6(5):297.","journal-title":"Endocr Connect"},{"issue":"7","key":"3980_CR14","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1007\/s10815-024-03146-1","volume":"41","author":"B Doroftei","year":"2024","unstructured":"Doroftei B, Ilie OD, Dabuleanu AM, Armeanu T, Maftei R. The pregnancy outcomes among women receiving individualized algorithm dosing with follitropin delta: a systematic review of randomized controlled trials. J Assist Reprod Genet. 2024;41(7):1851\u201361. https:\/\/doi.org\/10.1007\/s10815-024-03146-1.","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"3980_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-017-0232-y","volume":"15","author":"E Nieschlag","year":"2017","unstructured":"Nieschlag E, Bouloux PG, Stegmann BJ, Shankar RR, Guan Y, Tzontcheva A, et al. An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism. Reprod Biol Endocrinol. 2017;15(1): 17. https:\/\/doi.org\/10.1186\/s12958-017-0232-y.","journal-title":"Reprod Biol Endocrinol"},{"issue":"8","key":"3980_CR16","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1210\/en.2018-00452","volume":"159","author":"A Ulloa-Aguirre","year":"2018","unstructured":"Ulloa-Aguirre A, Reiter E, Crepieux P. FSH receptor signaling: complexity of interactions and signal diversity. Endocrinology. 2018;159(8):3020\u201335. https:\/\/doi.org\/10.1210\/en.2018-00452.","journal-title":"Endocrinology"},{"key":"3980_CR17","doi-asserted-by":"publisher","unstructured":"Misell LM, Holochwost D, Boban D, Santi N, Shefi S, Hellerstein MK, et al. A stable isotope-mass spectrometric method for measuring human spermatogenesis kinetics in vivo. J Urol. 2006;175(1):242\u20136; discussion 6.https:\/\/doi.org\/10.1016\/S0022-5347(05)00053-4.","DOI":"10.1016\/S0022-5347(05)00053-4"},{"key":"3980_CR18","unstructured":"World Health Organization. WHO laboratory manual for the examination and processing of human semen. 6th ed. Geneva: World Health Organization. 2021."},{"issue":"2","key":"3980_CR19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.5935\/1518-0557.20240104","volume":"29","author":"E Adolfsson","year":"2025","unstructured":"Adolfsson E, Ingberg J, Igersten E, Bohlin T. Clinical validation and experiences of the microfluidics sperm selection device ZyMot for standard IVF. JBRA Assist Reprod. 2025;29(2):244\u201350. https:\/\/doi.org\/10.5935\/1518-0557.20240104.","journal-title":"JBRA Assist Reprod"},{"key":"3980_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.636038","volume":"12","author":"JA Dias","year":"2021","unstructured":"Dias JA, Ulloa-Aguirre A. New human follitropin preparations: how glycan structural differences may affect biochemical and biological function and clinical effect. Front Endocrinol (Lausanne). 2021;12: 636038. https:\/\/doi.org\/10.3389\/fendo.2021.636038.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"3980_CR21","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/jsm.12890","volume":"12","author":"EP Wenker","year":"2015","unstructured":"Wenker EP, Dupree JM, Langille GM, Kovac J, Ramasamy R, Lamb D, et al. The use of HCG-based combination therapy for recovery of spermatogenesis after testosterone use. J Sex Med. 2015;12(6):1334\u20137. https:\/\/doi.org\/10.1111\/jsm.12890.","journal-title":"J Sex Med"},{"key":"3980_CR22","doi-asserted-by":"publisher","unstructured":"Stocks B, Oppenheimer A, Huang J, Lipshultz L. (085) Optimal restoration of spermatogenesis following testosterone therapy using HCG and FSH. J Sex Med. 2024;21(Issue Supplement_7):qdae167.083. https:\/\/doi.org\/10.1093\/jsxmed\/qdae167.083","DOI":"10.1093\/jsxmed\/qdae167.083"},{"issue":"2","key":"3980_CR23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.fertnstert.2016.10.004","volume":"107","author":"TP Kohn","year":"2017","unstructured":"Kohn TP, Louis MR, Pickett SM, Lindgren MC, Kohn JR, Pastuszak AW, et al. Age and duration of testosterone therapy predict time to return of sperm count after human chorionic gonadotropin therapy. Fertil Steril. 2017;107(2):351-7.e1. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.10.004.","journal-title":"Fertil Steril"},{"key":"3980_CR24","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf588","author":"JV Gialouris","year":"2025","unstructured":"Gialouris JV, Conway AJ, Idan A, Savkovic S, Hermosilla R, Muir CA, et al. Efficacy of gonadotropin therapy to induce spermatogenesis and fertility in men with pathologic gonadotropin deficiency. J Clin Endocrinol Metab. 2025. https:\/\/doi.org\/10.1210\/clinem\/dgaf588.","journal-title":"J Clin Endocrinol Metab"},{"key":"3980_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.clineuro.2016.01.029","volume":"144","author":"J Peng","year":"2016","unstructured":"Peng J, Qiu M, Qi S, Li D, Peng Y. Hypopituitarism patterns among adult males with prolactinomas. Clin Neurol Neurosurg. 2016;144:112\u20138. https:\/\/doi.org\/10.1016\/j.clineuro.2016.01.029.","journal-title":"Clin Neurol Neurosurg"},{"issue":"6","key":"3980_CR26","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1007\/s11102-022-01259-3","volume":"25","author":"Y Rudman","year":"2022","unstructured":"Rudman Y, Duskin-Bitan H, Masri-Iraqi H, Akirov A, Shimon I. Predicting hypogonadotropic hypogonadism persistence in male macroprolactinoma. Pituitary. 2022;25(6):882\u201390. https:\/\/doi.org\/10.1007\/s11102-022-01259-3.","journal-title":"Pituitary"},{"key":"3980_CR27","doi-asserted-by":"publisher","unstructured":"Nyboe Andersen A, Nelson SM, Fauser BC, Garcia-Velasco JA, Klein BM, Arce JC, et al. Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial. Fertil Steril. 2017;107(2):387-96 e4. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.10.033.","DOI":"10.1016\/j.fertnstert.2016.10.033"},{"issue":"9","key":"3980_CR28","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1093\/humrep\/deaf119","volume":"40","author":"A Bernabeu","year":"2025","unstructured":"Bernabeu A, Zajc P, Garcia Sanchez M, Agrawal R, Papaleo E, Jirecek S, et al. Ovarian stimulation with follitropin delta for in vitro fertilization: a multicentre, randomized, assessor-blind comparison with follitropin alfa using conventional dosing regimens (ADAPT-1 trial). Hum Reprod. 2025;40(9):1660\u201370. https:\/\/doi.org\/10.1093\/humrep\/deaf119.","journal-title":"Hum Reprod"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-026-03980-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-026-03980-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-026-03980-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:04:38Z","timestamp":1793754278000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-026-03980-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3980"],"URL":"https:\/\/doi.org\/10.1007\/s10815-026-03980-5","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethical standards of the Centro de Uro-Androlog\u00eda S.C., Guadalajara, Jalisco, Mexico (#2\u20142025).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from the patient.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent for publication was obtained from the patient.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}